GoodRx Holdings (GDRX) Change in Account Payables (2019 - 2026)

GoodRx Holdings has reported Change in Account Payables for 8 years, with the latest figure at -$4.9 million in Q1 2026.

• Quarterly Change in Account Payables fell 1829.02% year-over-year to -$4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.1 million (up 91.38% YoY) and the FY2025 annual result came in at $4.1 million, up 125.94% from the prior year.
• Change in Account Payables improved to -$4.9 million in Q1 2026 per GDRX's latest filing, from -$10.5 million in the prior quarter.
• Over five years, Change in Account Payables peaked at $25.5 million in Q3 2023 and troughed at -$15.6 million in Q2 2024.
• A 5-year average of -$323588.2 and a median of -$2.5 million in 2023 frame the typical range for Change in Account Payables.
• The sharpest annual moves came in 2022 and 2026: Change in Account Payables jumped 10030.77% in 2022, then sank 1829.02% in 2026.
• Over 5 years, Change in Account Payables stood at $7.1 million in 2022, then sank by 134.76% to -$2.5 million in 2023, then surged by 396.17% to $7.3 million in 2024, then tumbled by 243.2% to -$10.5 million in 2025, then jumped by 53.0% to -$4.9 million in 2026.
• According to Business Quant data, Change in Account Payables over the past three periods registered -$4.9 million, -$10.5 million, and $3.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.